Potential role of TGF-β in diabetic nephropathy

Mineral and Electrolyte Metabolism

Volumn 24, Issue 2-3, 1998, Pages 190-196

  Hoffman, Brenda B ^a   Sharma, Knmar ^b   Ziyadeh, Fuad N ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Angiotensin II; Collagen; Endothelin; Glomerulus; Glucose; Glycation; Platelet derived growth factor; Thromboxane; Tubulointerstitium

Indexed keywords

ANTIBODY; ANTISENSE OLIGODEOXYNUCLEOTIDE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

DIABETES MELLITUS; DIABETIC NEPHROPATHY; EXTRACELLULAR MATRIX; GLOMERULUS; KIDNEY DISEASE; KIDNEY PROXIMAL TUBULE; MESANGIUM CELL; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELLS, CULTURED; DIABETIC NEPHROPATHIES; GENE EXPRESSION; GLUCOSE; HUMANS; TRANSFORMING GROWTH FACTOR BETA;

GLOMERULUS;

EID: 0031883395     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057369     Document Type: Review

References (79)

1. The Diabetes Control and Complications Trial Research Group: The effects of intensive insulin treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
2. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin- converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-1462.
3. Mogyorosi A, Ziyadeh FN: Update on pathogenesis, markers, and management of diabetic nephropathy. Curr Opin Nephrol Hypertens 1996;5:243-253.
4. Ziyadeh FN: Mediators of hyperglycemia and the pathogenesis of matrix accumulation in diabetic renal disease. Miner Electrolyte Metab 1995;21:292-302.
5. Rocco M, Chen Y, Goldfarb S, Ziyadeh FN: Elevated glucose stimulates TGF-β gene expression and bioactivity in proximal tubule. Kidney Int 1992;41:107-114.
6. Wolf G, Sharma K, Chen Y, Ericksen M, Ziyadeh FN: High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int 1992;42:647-656.
7. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by activation of trans-forming growth factor-β. J Clin Invest 1994;93: 536-542.
8. Rocco MV, Ziyadeh FN: Transforming growth factor-beta: An update on systemic and renal actions; in Goldfarb S, Ziyadeh FN (eds): Hormones, Autacoids, and the Kidney. New York, Churchill-Livingstone, 1991, vol 21, pp 391-410.
9. Sharma K, Ziyadeh FN: Hyperglycemia and diabetic kidney disease: The case for transforming growth factor-β as a key mediator. Diabetes 1995;44:1139-1146.
10. Ziyadeh FN: The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 1993;22: 736-744.
11. Ziyadeh FN, Snipes ER, Watanabe M, Alvarez RJ, Goldfarb S, Haverty TP: High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am J Physiol 1990;259:F704-F714.
12. Ayo SH, Radnik RA, Garoni JA, Glass WFII, Kreisberg JI: High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 1990;136:1339-1348.
13. Ayo SH, Radnik R, Garoni JA, Kreisberg J: High glucose increases diacylglycerol mass and activates protein kinases C in mesangial cell culture. Am J Physiol 1991;261:F571-F577.
14. Ayo SH, Radnik RA, Glass WFII, Garoni JA, Rampt ER, Appling DR, Kreisberg JI: Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 1991;260:F185-F191.
15. Haneda M, Kikkawa R, Horide N, Togawa M, Koya D, Kajiwara N, Ooshima A, Shigeta Y: Glucose enhances type IV collagen production in cultured rat glomerular mesangial cells. Diabetologia 1991;34:491-499.
16. Danne T, Spiro MJ, Spiro RG: Effect of high glucose on type IV collagen production by cultured glomerular epithelial, endothelial, and mesangial cells. Diabetes 1993;42:170-177.
17. Nahman NS, Leonhart KL, Cosio FG, Hebert CL: Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells. Kidney Int 1992;41: 396-402.
18. Wakisaka M, Spiro MJ, Spiro RG: Synthesis of type VI collagen cultured glomerular cells and comparison of its regulation by glucose and other factors with that of type IV collagen. Diabetes 1994;43:95-103.
19. Kolm V, Sauer U, Olgemoller B, Schleicher ED: High glucose-induced TGF-β1 regulates mesangial production of heparan sulfate proteoglycan. Am J Physiol 1996;270:F812-F821.
20. van Del NF, Verhagen NAM, Tamsma JT, Berden JHM, Bruijn JA, Daha MR, van der Woulde FJ: Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-β by high glucose, not by angiotensin II. Diabetes 1997;46:834-840.
21. Takeuchi A, Throckmorton DC, Brogden AP, Yoshizawa N, Rasmussen H, Kashgarian M: Periodic high extracellular glucose enhances production of collagens III and IV by mesangial cells. Am J Physiol 1995;268:F13-F19.
22. Heilig CW, Concepcion LA, Riser BL, Freytag SO, Cortes P: Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 1995;96:1802-1814.
23. Ziyadeh FN: Renal tubular basement membrane and collagen type IV in diabetes mellitus. Kidney Int 1993;43:114-120.
24. Cohen MP, Ziyadeh FN: Role of Amadorimodified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy. J Am Soc Nephrol 1996;7:1-8.
25. McLennan SV, Fisher EJ, Yue DK, Turtle JR: High glucose concentration causes a decrease in mesangium degradation: A factor in the pathogenesis of diabetic nephropathy. Diabetes 1994;43:1041-1045.
26. Leehey DJ, Hua Song R, Alavi N, Singh AK: Decreased degradative enzymes in mesangial cells cultured in high glucose media. Diabetes 1995;44:929-935.
27. Song RH, Singh AK, Alavi N, Leehey DJ: Decreased collagenase activity of mesangial cells incubated in high glucose media is reversed by neutralizing antibody to transforming growth factor beta (abstract). J Am Soc Nephrol 1994;5:972.
28. Sharma K, Ziyadeh FN: The emerging role of transforming growth factor-β in kidney diseases. Am J Physiol 1994;35:F829-F842.
29. Border WA, Noble NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994;331:1286-1292.
30. Roberts AB, McCune BK, Sporn MB: TGF-β: Regulation of extracellular matrix. Kidney Int 1992;41:557-559.
31. Laiho M, Saksela O, Andreasen PA, Keski-Oja J: Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta. J Cell Biol 1986;103:2403-2410.
32. Heino J, Ignotz RA, Hemler ME, Crouse C, Massague J: Regulation of cell adhesion receptors by transforming growth factor-β: Concomitant regulation of integrins that share a com-mon β1 subunit. J Biol Chem 1989;264:380-388.
33. Ziyadeh FN, Simmons DA, Snipes ER, Goldfarb S: Effect of myo-inositol on cell proliferation and collagen transcription and secretion in proximal tubule cells cultured in elevated glucose. J Am Soc Nephrol 1991;1:1220-1229.
34. Mogyorosi A, Huffman BB, Guo J, Jin Y, Ericksen M, Sharma K, Ziyadeh FN: Elevated glucose concentration stimulates expression of the type II receptor in glomerular mesangial cells (abstract). J Am Soc Nephrol 1996;7: 1875.
35. Guh JY, Yang ML, Yanf YY, Chang CC, Chuang LY: Captopril reverses high-glucose induced growth effects on LLC-PK1 cells partly by decreasing transforming growth factor-β receptor protein expression. J Am Soc Nephrol 1996;7:1207-1215.
36. Choi ME, Kim E-G, Huang Q, Ballermann BJ: Rat mesangial cell hypertrophy in response to transforming growth factor-β 1. Kidney Int 1993;44:948-958.
37. Di Paolo S, Gesualdo L, Ranieri E, Grandaliano G, Schena FP: High glucose concentration induces the overexpression of transforming growth factor-β through the activation of a platelet-derived growth factor loop in human mesangial cells. Am J Pathol 1996;149:2095-2106.
38. Phillips AO, Steadman R, Topley N, Williams JD: Elevated D-glucose concentrations modulate TGF-beta 1 synthesis by human cultured renal proximal tubular cells: The permissive role of platelet-derived growth factor. Am J Pathol 1995;147:362-374.
39. Kreisberg JI, Radnik R, Kreisberg SH: Phosphorylation of cAMP responsive element binding protein after treatment of mesangial cells with high glucose plus TGF-β or PMA. Kidney Int 1996;50:805-810.
40. Sharma K, Ziyadeh FN: Renal hypertrophy is associated with upregulation of TGF-β1 gene expression in diabetic BB rat and NOD mouse. Am J Physiol 1994;267:F1094-F1101.
41. Pankewycz OG, Guan JX, Bolton WK, Gomez A, Benedict JF: Renal TGF- beta regulation in spontaneously diabetic NOD mice with correlations in mesangial cells. Kidney Int 1994;46: 748-758.
42. Shankland SJ, Scholey JW: Expression of transforming growth factor-β1 during diabetic renal hypertrophy. Kidney Int 1994;46:430-442.
43. Yang S, Fletcher WH, Johnson DA: Regulation of cAMP-dependent protein kinase: Enzyme activation without dissociation. Biochem 1995; 34:6267-6271.
44. Park I-S, Kiyomoto H, Abboud S, Abboud H: Expression of transforming growth factor-β and type IV collagen in early streptozotocininduced diabetes. Diabetes 1997;46:473-480.
45. Sharma K, Guo J, Jin Y, Ziyadeh FN: Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 1996;45:522-530.
46. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 1993;90:1814-1818.
47. Nakamura T, Fukui M, Ebihara I, Osada S, Nagaoka I, Tomino Y, Koide H: mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 1993;42:450-456.
48. Bertoluci MC, Schmid H, Lachat J-J, Coimbra TM: Transforming growth factor-beta in the development of rat diabetic nephropathy: A 10-month study with insulin-treated rats. Nephron 1996;74:189-196.
49. Han DC, Kim YJ, Cha MK, Song KI, Kim JH, Lee EY, Ha H, Lee HB: Glucose control suppressed the glomerular expression of TGF-pl and the progression of experimental diabetic nephropathy (abstract). J Am Soc Nephrol 1996;7:1870.
50. Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, Gold LI, Border WA: Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int 1996;49: 461-469.
51. Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H, Maki S: Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 1993;68:154-163.
52. Iwano M, Atsushi K, Nishino T, Sato H, Nishioka H, Akai Y, Kurioka H, Fuji Y, Kanauchi M, Shiiki H, Dohi K: Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitus. Kidney Int 1996;49:1120-1126.
53. Sharma K, Ziyadeh FN, Alzahabi B, McGowan TA, Kapoor S, Kurnik BRC, Kurnik PB, Weisberg LS: Increased renal production of transforming growth factor-β 1 in patients with type II diabetes. Diabetes 1997;46:854-859.
54. Sharma K, Ziyadeh FN: Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. Semin Nephrol 1997;17:80-92.
55. Wolf G, Ziyadeh F: The role of angiotensin II in diabetic nephropathy: Emphasis on nonhemodynamic mechanisms. Amer J Kidney Dis 1997;29:153-163.
56. Hoffman BB, Ziyadeh FN: The role of growth factors in the development of diabetic nephropathy. Curr Opin Endocrinol Diabetes 1996;3:322-329.
57. Hoffman B, Sharma K, Ericksen M, Ziyadeh F: Transcriptional activation of TGF-β1 by high glucose (abstract). J Am Soc Nephrol 1995;6: 1041.
58. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL: Preferential elevation of protein kinase C isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats: Differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 1992;89:11059-11063.
59. DeRubertis FR, Craven P: Activation of protein kinase C in glomerular cells in diabetes: Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 1994;43:1-8.
60. Studer RK, Negrete H, Craven PA, DeRubertis FR: Protein kinase C signals thromboxane induced increases in fibronectin synthesis and TGF-beta bioactivity in mesangial cells. Kidney Int 1995;48:422-430.
61. Negrete H, Studer RK, Craven PA, DeRubertis FR: Role for transforming growth factor beta in thromboxane-induced increases in mesangial cell fibronectin synthesis. Diabetes 1995;44: 335-339.
62. de Groot RP, Auwerx J, Karperien M, Staels B, Kruijer W: Activation of JunB by PKC and PKA signal transduction through a novel cisacting element. Nucl Acids Res 1991;19:775-781.
63. Shankland SJ, Scholey JW: Expression of growth-related protooncogenes during diabetic renal hypertrophy. Kidney Int 1995;47:782-788.
64. Kim S-J, Click A, Sporn MB, Roberts AB: Characterization of the promoter region of the human transforming growth factor-β1 gene. J Biol Chem 1989;264:402-408.
65. Ziyadeh FN, Mogyorosi A, Kalluri R: Early and advanced nonenzymatic glycation products in the pathogenesis of diabetic kidney disease. Exp Nephrol 1997;5:2-9.
66. Yang C-W, Vlassara H, Peten EP, He C-J, Striker GE, Striker LJ: Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci USA 1994;91:9436-9440.
67. Skolnik EY, Yang Z, Makita Z, Radoff S, Kirstein M, Vlassara H: Human and rat mesangial cell receptors for glucose-modified proteins: Potential role in kidney tissue remodeling and diabetic nephropathy. J Exp Med 1991;174: 931-939.
68. Doi TT, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker L: Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via plateletderived growth factor. Proc Natl Acad Sci USA 1992;89:2873-2877.
69. Wolf G, Mueller E, Stahl RAK, Ziyadeh FN: Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells by endogenous TGF-β. J Clin Invest 1993;92:1366-1373.
70. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 1994;93: 2431-2437.
71. Nakamura T, Ebihara I, Fukui M, Tomino Y, Koide H: Effect of a specific endothelin receptor A antagonist on'mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli. Diabetes 1995;44:895-899.
72. Throckmorton DC, Brogden AP, Min B, Rasmussen H, Kashgarian M: PDGF and TGF-β mediate collagen production by mesangial cells exposed to advanced glycation end products. Kidney Int 1995;48:111-117.
73. Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1981;19:410-415.
74. Riser BL, Cortes P, Zhao X, Bernstein J, Dumier F, Narins RG: Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. J Clin Invest 1992;90:1932-1943.
75. Yasuda T, Satoshi K, Homma T, Harris RC: Regulalion of extracellular matrix by mechanical stress in ral glomerular mesangial cells. J Clin Invest 1996;98:1991-2000.
76. Riser BL, Cortes P, Heilig C, Grondin J, Ladsonwofford S, Palterson D, Narins RG: Cyclic stretching force selectively up-regulates transforming growth factor-beta isoforms in cultured rat mesangial cells. Am J Pathol 1996; 148:1915-1923.
77. Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH: The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: A meta analysis. Ann Intern Med 1996;124:627-632.
78. Okuda S, Nakamura T, Yamamoto T, Ruoslahti E, Border WA: Dietary protein restriction rapidly reduces transforming growth factor-β1 expression in experimental glomerulonephritis. Proc Natl Acad Sci USA 1991;88:9765-9769.
79. Eddy AA: Protein restriction reduces transforming growth factor-beta and interstitial fibrosis in nephrotic syndrome. Am J Physiol 1994;266:F884-F893.